UHealth - University of Miami Health System

E-mail a Friend

Bonnie Levin, Ph.D.

General Information

Bonnie  Levin, Ph.D.


  • Fax: 305-243-8108


  • Clinical Psychology
  • Clinical Neuropsychology




  • Chief, Neuropsychology Division
  • Professor of Neurology Tenured

Research Interests

Cognitive and behavioral changes associated with PD; cognitive sequelae following deep brain stimulation; aging,cognition, and white matter changes; neuropsychological changes following exposure to marine and occupational toxins.



Georgetown University
Temple University
Clinical Fellow, Psychology
Harvard Medical School
Boston Children's Hospital
Boston VA Hospital


Dr. Bonnie Levin is the Alexandria and Bernard Schoninger Professor of Neurology and Director of the Division of Neuropsychology in the Department of Neurology at the University of Miami, Miller School of Medicine. She received her BS from Georgetown University and her Ph.D. from Temple University. She completed an internship at the Boston Children’s Hospital where she was a clinical fellow in Psychiatry at Harvard Medical School and an externship at the Boston VA Hospital.


Dr. Levin is a neuropsychologist whose research examines neurocognitive and affective changes associated with neurodegenerative disease and the normative aging process. Her work examines the role of cardiometabolic risk factors in cognitive decline. Another focus has been the inter-relationship between behavioral and motor symptoms in Parkinson’s disease and the neural circuitry underlying memory and age related cognitive change. Her current work is aimed to advance our understanding of frontal striatal circuit function in cognition and to generate data that will improve our knowledge of key clinical parameters associated with differential rates of cognitive decline. Current projects include: examining which components of the metabolic syndrome predict cognition, identifying imaging and clinical correlates of white matter changes associated with the aging process and linking structural and metabolic markers underlying different symptom profiles in neurodegenerative disease.




E-mail a Friend